Upload
others
View
7
Download
0
Embed Size (px)
Citation preview
K award NIH Biosketchhttps://grants.nih.gov/grants/forms/biosketch.htm
KarlaKerlikowske,MDProfessorofMedicineandEpidemiologyandBiostatistics
1
School of Medicine
What is NIH Biographical Sketch?• Highly formatted component of a
grant proposal that captures and communicates the PI’s accomplishments and activities as clearly and effectively as possible
• A concise “personal narrative” of education, training, experiences, contributions, and leadership in profession/field
2
School of Medicine
Why is the NIH Biographical Sketch Needed? Allows PIs to:• Highlight education, training, experiences,
and qualifications• Describe magnitude and significance of
scientific contributions (plus publications)• Provide significant contributions, relevant
experiences, and/or qualifications in the context of the proposed project
• Enables reviewers to evaluate experience and qualifications of the PI and scientific team that will execute the grant
3
School of Medicine
In a Nut Shell: Your Biosketch Tells Your Story• Who you are• What makes you great for this
project• What contributions you have made
4
School of Medicine
Components
• Limit of 5 pages• A. Personal statement -1/2 pgs.• B. Positions and honors-1/2 pgs.• C. Contributions to Science – 2 pgs.• D. Research support and scholastic
performance -2 pgs.
5
School of Medicine
NIH biosketch●Name●eRA commons
⁃ RMS Research Services Coordinator
●Position Title●Education
⁃ name and location of the institution⁃ degree received (if applicable)⁃ month and year of end date (or
expected end date) ⁃ field of study
6
School of Medicine
7
OMB No. 0925-0001 and 0925-0002 (Rev. 09/17 Approved Through 03/31/2020)
BIOGRAPHICAL SKETCH Provide the following information for the Senior/key personnel and other significant contributors.
Follow this format for each person. DO NOT EXCEED FIVE PAGES.
NAME: Kim, Tiffany Y. eRA COMMONS USER NAME (credential, e.g., agency login): tiffany.kim POSITION TITLE: Assistant Professor of Medicine EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, include postdoctoral training and residency training if applicable. Add/delete rows as necessary.)
INSTITUTION AND LOCATION DEGREE (if applicable)
Completion Date
MM/YYYY FIELD OF STUDY
University of California, Berkeley BA 05/2007 Molecular and Cell Biology
University of Illinois at Chicago MD 05/2011 Medicine
University of California, Los Angeles Residency 06/2014 Internal Medicine
University of California, San Francisco Certificate 06/2016 Advanced Training in Clinical Research
University of California, San Francisco Fellowship 06/2017 Endocrinology
San Francisco VA Health Care System Fellowship 06/2019 Women’s Health A. Personal Statement
I am an endocrinologist, Assistant Professor of Medicine at the University of California, San Francisco
(UCSF) and Staff Physician at the San Francisco VA Health Care System (SFVAHCS). My long-term goal is to become an independent clinical investigator focused on understanding mechanisms of diabetic bone disease and improving the skeletal health of people with type 2 diabetes. I am the Principal Investigator for this K23 proposal, which seeks to examine the role of bone marrow fat in diabetic bone disease.
School of Medicine
Personal statement• 3-paragraph statement with the
following content:• Proposal goal• Relevant experiences on this
specific topic or related topic • Leadership qualifications
8
School of Medicine
Personal statement tip• Tailor to the grant application• Mention the mechanism of the grant
application (e.g., K01)• Speak directly to the purpose of the
funding mechanism and proposal goal• Ex: My goal for this proposed NCI Career
Development Award (K01, K08) or Transition Award (K22) is to conduct basic, translational, or clinical research to study … while further developing and expanding my (training and) career growth in the field of …(or as a…) or etc.
9
School of Medicine
Personal statement tip• Sell your role in the proposed research
• Why are you a good fit?• What strengths do you have for the
proposal?• Identify yourself – New Investigator – and
discuss your future research direction if you are a new investigator
• Write in first person and limit your personal statement to 300‒400 words (about half a page)
• If someone is mentoring/collaborating with you, include this in the personal statement
10
School of Medicine
Personal statement examples• I am a clinician-investigator with a
longstanding interest in …..• I have the expertise, leadership and
training in x to carry out the proposed research
• I have a broad background in x with specific training in ….
• My research has evolved from x experience• As an investigator on x grants, I laid the
groundwork for the proposed research by…• I collaborated with x, an expert in x• The proposed studies began under the
mentorship of x11
School of Medicine
Personal statement●Up to 4 publications/research
products●Directly related to research topic●Articles with co-investigators
12
School of Medicine
Personal statement●Research products●Audio or video products●Conference proceedings -- meeting
abstracts, posters, presentations ●Patents ●Data and research materials;
databases; educational aids or curricula; instruments or equipment; models; protocols; and software or netware
13
School of Medicine
14
A. Personal Statement I am a clinician-investigator with a longstanding interest in improving cancer screening and prevention. My research has evolved from describing the unintended effects of cancer screening to studying novel approaches to screening that are informed by individual risk. My current research focuses on developing risk stratification tools to allow personalization of breast cancer screening and prevention, with a special focus on integrating circulating biomarkers and existing risk prediction models. For instance, I have shown that genetic variants and sex hormones can improve the performance of risk models based on clinical risk factors. As an investigator in the WISDOM Study, an ongoing randomized trial of personalized versus annual breast cancer screening, I am studying how to integrate risk models into clinical decision-making around screening and prevention, and whether this practice improves outcomes. This K08 proposal aims to extend my prior work by developing and validating a risk model that accounts for breast cancer phenotype, enabling screening and prevention to target the aggressive cancers most likely to cause morbidity and mortality.
1. Esserman L, Shieh Y, Thompson I. Rethinking screening for breast cancer and prostate cancer. JAMA. 2009 Oct 21; 302(15):1685-92. PMID: 19843904
2. Shieh Y, Eklund M, Sawaya GF, Black WC, Kramer BS, Esserman LJ. Population-based screening for cancer: hope and hype. Nat Rev Clin Oncol. 2016 Sep; 13(9):550-565. PMID: 27071351
3. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016 Oct; 159(3):513-25. PMID: 27565998. PMCID: PMC5033764
4. Shieh Y, Eklund M, Madlensky L, Sawyer SD, Thompson CK, Stover Fiscalini A, Ziv E, Van't Veer LJ, Esserman LJ, Tice JA. Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. J Natl Cancer Inst. 2017 Jan; 109(5). PMID: 28130475
School of Medicine
Position and Honors●Positions and Employment●Other Experience and Professional
Memberships●Honors – clarify what for●Scholarship●Traineeship●Fellowship●Research Prize
15
School of Medicine
Contributions to Science (2 pages)● Describe up to 5 of your most significant
contributions to science –1/2 page, including up to 4 published citations (PMC or NIHMS)●Historical background that frames the
scientific problem●Central finding(s)● Influence of the finding(s) on the
progress of science or the application of those finding(s) to health or technology –So what?
● Your specific role in the described work
16
School of Medicine
Contributions to Science● Historical background that frames the
scientific problem● Similar to background sentence of
abstract● Central finding(s)●My publication was the first to show ….●My publication has contributed
evidence of ….●We identified a molecular signature
that stratified....●We developed a risk model or
nomogram to predict......17
School of Medicine
Contributions to Science● Influence of the finding(s) on the progress
of science or the application of those finding(s) to health or technology
• My results contributed to a growing body of evidence that ….
• My findings have important implications for clinical care of …
• The risk calculator/nomogram/app that I helped is available on the iPhone and facilitates …..
• My contributions have been cited when establishing xx guidelines
• This work led to two patents and development of a commercial test
18
School of Medicine
Contributions to Science● Your specific role in the described work ●My first authored paper showed….● I served as the primary investigator or
senior investigator for these studies.●With a team of collaborators we
developed x with my contribution to the project ….
● Complete list of x# published works in MyBibliography:
https://www.ncbi.nlm.nih.gov/books/NBK53595/http://www.ncbi.nlm.nih.gov/pubmed/?term=kerlikowske+k
19
School of Medicine
20
C. Contribution to Science1. Genetic variants and other circulating markers in breast cancer risk
assessment. Over 150 genetic variants, or single nucleotide polymorphisms (SNPs), have been associated with breast cancer risk, but their role in informing clinical risk prediction is still being elucidated. I showed that a polygenic risk score (PRS) representing the cumulative effect of 83 SNPs had a strong association with breast cancer that was largely independent of family history and other risk factors. Moreover, incorporating the PRS into an established risk model containing clinical risk factors and breast density resulted in improved discrimination and reclassification. These results contributed to a growing evidence base that PRS may enhance risk stratification. I was also the lead author on the first study on the combined effects of sex hormones, SNPs, and clinical risk factors in breast cancer risk predication. My coauthors and I showed that sex hormones could improve prediction of estrogen-receptor positive breast cancers, results that could potentially be used to better identify high-risk women for chemoprevention.
a. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JW, Tice JA, Vachon CM, Cummings SR, Kerlikowske K, Ziv E. Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat. 2016 Oct; 159(3):513-25. PMID: 27565998. PMCID: PMC5033764
b. Shieh Y, Hu D, Ma L, Huntsman S, Gard CC, Leung JWT, Tice JA, Ziv E, Kerlikowske K, Cummings SR. Joint relative risks for estrogen receptor-positive breast cancer from a clinical model, polygenic risk score, and sex hormones. Breast Cancer Res Treat. 2017 Aug 08. PMID: 28791495. PMCID: PMC5669824
School of Medicine
Additional information: research support and/or scholastic performance (2 pages)●Ongoing Research Support●Completed Research Support
21
D. Research Support
Ongoing Research Support K12HL138046 NHLBI Garcia (PI) 07/01/2018-present
Implementing Depression Screening and Care for Patients with CVD and Language Barriers
Cardiovascular disease (CVD) and comorbid depression lead to increased morbidity and mortality.
Patients with CVD and language barriers face additional challenges to obtaining care for depression
in primary care. This study sought to identify ways to improve care for vulnerable patients with CVD
and language barriers.
Completed/Past Research Support D55HP23202 Margot Kushel (PI) Role: Research Fellow 07/01/14-06/30/17
HRSA
Faculty Development in Primary Care (UCSF)
This grant provided fellowship level support for three years to acquire methodological research skills
in addition to mentored research experience with established investigators at the University of
California, San Francisco.
School of Medicine
Thank you
22